Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Showing Most Recent
1-20 of 2657
Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
The "MetaboMap" project Anindya Roy University of Maryland Baltimore County PLCO Mar 4, 2026 PLCO-2030
Continuation of Novel Dietary Index for Gut Microbiota and Associations with Colorectal Cancer and Breast Cancer Risk PLCO-730 Susan Steck University of South Carolina PLCO Mar 4, 2026 PLCO-2029
Development of ML-Based Early Cancer Confirmation and Stage Classification Models for Ovarian and Colorectal Cancer Using PLCO Trial Data Dr. Mehdi Hasan Chowdhury Chittagong University of Engineering & Technology (CUET) PLCO Mar 4, 2026 PLCO-2026
Effect of Stage and Grade on Colorectal Cancer Mortality Paul Pinsky National Institutes of Health PLCO Feb 26, 2026 PLCO-2028
Early Risk Prediction of Ovarian Cancer Using Multimodal Clinical and Biomarker Data Vanshika Sharma Chandigarh University PLCO Feb 23, 2026 PLCO-2020
A Risk-Stratified Decision Support Framework for Prostate Cancer Screening Using the PLCO Trial Dataset Priya Dubey Tokyo International University PLCO Feb 23, 2026 PLCO-2014
Validation of CA-125 Kinetic Models for Early Ovarian Cancer Detection Using Machine Learning Fahad Kiani CrisPRO.ai PLCO Feb 23, 2026 PLCO-2010
Standardization of Imaging Interpretation for Early Lung Cancer Detection, Intelligent Learning Platforms, and Public Education Outreach Dr. Yeun-Chung Chang The Radiological Society of the Republic of China (RSROC) NLST Feb 20, 2026 NLST-1493
Plasma proteomics markers for risk prediction of incident lung cancer Charles Swanton Francis Crick Institute PLCO Feb 19, 2026 2025-0069
DNA methylation and dietary sodium intake Jeong Yun (John) Yang Columbia University Irving Medical Center PLCO Feb 17, 2026 PLCO-2023
Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer Susan Steck University of South Carolina PLCO Feb 13, 2026 PLCO-2021
Computational Prediction of Gene Expression and Clinical Outcomes from Digital Pathology Images Mingyao Li University of Pennsylvania PLCO Feb 13, 2026 PLCOI-2022
Validation of a Morphology-Based Risk Taxonomy (Favorable, Borderline, Unfavorable Histology) for Prostate Cancer Using PLCO Trial Data Enrico Munari University Hospital Trust Verona PLCO Feb 4, 2026 PLCOI-2019
Bone Marrow Extracellular Matrix Gene Expression Analysis for Cancer Prognosis and Bone Metastasis Prediction: An 82-Gene Panel Study Using PLCO Trial Data Shelly Peyton Trustees of Tufts College PLCO Feb 4, 2026 PLCO-2011
Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models Hansapani Rodrigo University of Texas Rio Grande Valley PLCO Feb 4, 2026 PLCO-2015
Calibration of a microsimulation model of lung cancer natural history in Australia Marianne Weber The University of Sydney NLST Feb 4, 2026 NLST-1495
Epstein-Barr virus-associated neo-antigens in advanced prostate cancer Denong Wang SRI International PLCO Feb 2, 2026 2025-0062
Evaluating lung cancer screening by competing mortality Rebecca Landy American Cancer Society NLST Jan 29, 2026 NLST-1496
Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort Kristian Stensland The University of Michigan PLCO Jan 26, 2026 PLCO-2012
Identifying histological features of lung cancer using deep learning Jennifer Beane Trustees of Boston University NLST Jan 26, 2026 NLST-1494